Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Follow-Up Study for Exubera (FUSE)

24. september 2012 oppdatert av: Pfizer

An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials

In studies of Exubera in persons with diabetes, lung cancer occurred in a few more people who were taking Exubera than in people who were taking other diabetes medicines. All subjects diagnosed with lung cancer had a history of smoking and the number of lung cancer cases observed fell within the expected range based on population-based data. There is currently not enough information to determine if any of the observed lung cancer cases were related to Exubera use, therefore, the study is being conducted to further investigate whether Exubera use makes the appearance of lung cancer more likely.

Studieoversikt

Status

Fullført

Forhold

Sukkersyke

Intervensjon / Behandling

Detaljert beskrivelse

Both retrospective and prospective components All subjects who participated in one of the 17 included Exubera clinical trials will be invited to participate in the current study.

Studietype

Observasjonsmessig

Registrering (Faktiske)

7439

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

Argentina
- - Buenos Aires, Argentina, C1426ABP
    - Pfizer Investigational Site
- Buenos Aires
  - Capital Federal, Buenos Aires, Argentina, C1181ACH
    - Pfizer Investigational Site
Australia
- New South Wales
  - Camperdown, New South Wales, Australia, 2050
    - Pfizer Investigational Site
  - Wollongong, New South Wales, Australia, 2500
    - Pfizer Investigational Site
- Queensland
  - Herston, Queensland, Australia, 4029
    - Pfizer Investigational Site
- Victoria
  - Box Hill, Victoria, Australia, 3128
    - Pfizer Investigational Site
  - Melbourne, Victoria, Australia, 3004
    - Pfizer Investigational Site
Belgia
- - Bornem, Belgia, 2880
    - Pfizer Investigational Site
  - Brussels, Belgia, 1070
    - Pfizer Investigational Site
  - Edegem, Belgia, 2650
    - Pfizer Investigational Site
  - Genk, Belgia, 3600
    - Pfizer Investigational Site
  - Leuven, Belgia, 3000
    - Pfizer Investigational Site
  - Liège 1, Belgia, 4000
    - Pfizer Investigational Site
Brasil
- MG
  - Belo Horizonte, MG, Brasil, 30150-221
    - Pfizer Investigational Site
- RS
  - Porto Alegre, RS, Brasil, 90035-170
    - Pfizer Investigational Site
- SP
  - Sao Paulo, SP, Brasil, 01244-030
    - Pfizer Investigational Site
  - Sao Paulo, SP, Brasil, 04025-011
    - Pfizer Investigational Site
Canada
- Alberta
  - Calgary, Alberta, Canada, T2L 1K8
    - Pfizer Investigational Site
  - Calgary, Alberta, Canada, T2T 5C7
    - Pfizer Investigational Site
  - Calgary, Alberta, Canada, T3B 0M3
    - Pfizer Investigational Site
  - Edmonton, Alberta, Canada, T5J 3N4
    - Pfizer Investigational Site
  - Edmonton, Alberta, Canada, T6G 2C8
    - Pfizer Investigational Site
  - Edmonton, Alberta, Canada, T6G 2S2
    - Pfizer Investigational Site
  - Red Deer, Alberta, Canada, T6N 6V7
    - Pfizer Investigational Site
- British Columbia
  - Victoria, British Columbia, Canada, V8R 1J8
    - Pfizer Investigational Site
- Manitoba
  - Winnipeg, Manitoba, Canada, R3E 3P4
    - Pfizer Investigational Site
- Newfoundland and Labrador
  - St. John's, Newfoundland and Labrador, Canada, A1A 2E2
    - Pfizer Investigational Site
- Nova Scotia
  - Halifax, Nova Scotia, Canada, B3H 1V7
    - Pfizer Investigational Site
  - Halifax, Nova Scotia, Canada, B3H 2Y9
    - Pfizer Investigational Site
- Ontario
  - Corunna, Ontario, Canada, N0N 1G0
    - Pfizer Investigational Site
  - London, Ontario, Canada, N6A 4V2
    - Pfizer Investigational Site
  - Mississauga, Ontario, Canada, L5M 2V8
    - Pfizer Investigational Site
  - Oakville, Ontario, Canada, L6H 3P1
    - Pfizer Investigational Site
  - Ottawa, Ontario, Canada, K1H 1A2
    - Pfizer Investigational Site
  - Smiths Falls, Ontario, Canada, K7A 4W8
    - Pfizer Investigational Site
  - Thornhill, Ontario, Canada, L4J 8L7
    - Pfizer Investigational Site
  - Toronto, Ontario, Canada, M4N-3M5
    - Pfizer Investigational Site
  - Toronto, Ontario, Canada, M4R 2G4
    - Pfizer Investigational Site
- Quebec
  - Chicoutimi, Quebec, Canada, G7H 5H6
    - Pfizer Investigational Site
  - Gatineau, Quebec, Canada, J8Y 6S9
    - Pfizer Investigational Site
  - Greenfield Park, Quebec, Canada, J4V 2H1
    - Pfizer Investigational Site
  - Laval, Quebec, Canada, H7T 2P5
    - Pfizer Investigational Site
  - Montreal, Quebec, Canada, H3A 1A1
    - Pfizer Investigational Site
  - Sherbrooke, Quebec, Canada, J1H 5N4
    - Pfizer Investigational Site
  - Trois Rivieres, Quebec, Canada, G8T 7A1
    - Pfizer Investigational Site
Danmark
- - Aarhus, Danmark, 8000
    - Pfizer Investigational Site
  - Copenhagen, Danmark, 2400
    - Pfizer Investigational Site
  - Herning, Danmark, 7400
    - Pfizer Investigational Site
Estland
- - Pärnu, Estland, 80018
    - Pfizer Investigational Site
  - Tallinn, Estland, 10318
    - Pfizer Investigational Site
  - Tallinn, Estland, 11625
    - Pfizer Investigational Site
  - Tallinn, Estland, 13415
    - Pfizer Investigational Site
- Viljandi mk.
  - Viljandi, Viljandi mk., Estland, 71024
    - Pfizer Investigational Site
Finland
- - Kuopio, Finland, 70210
    - Pfizer Investigational Site
  - Lahti, Finland, 15110
    - Pfizer Investigational Site
  - Lohja, Finland, 08200
    - Pfizer Investigational Site
  - Oulu, Finland, 90100
    - Pfizer Investigational Site
Forente stater
- Alabama
  - Bay Minette, Alabama, Forente stater, 36507
    - Pfizer Investigational Site
  - Graysville, Alabama, Forente stater, 35073
    - Pfizer Investigational Site
  - Pell City, Alabama, Forente stater, 35125
    - Pfizer Investigational Site
  - Pell City, Alabama, Forente stater, 35128
    - Pfizer Investigational Site
- Arizona
  - Glendale, Arizona, Forente stater, 85306
    - Pfizer Investigational Site
  - Phoenix, Arizona, Forente stater, 85006
    - Pfizer Investigational Site
  - Phoenix, Arizona, Forente stater, 85016
    - Pfizer Investigational Site
  - Phoenix, Arizona, Forente stater, 85028
    - Pfizer Investigational Site
  - Phoenix, Arizona, Forente stater, 85051
    - Pfizer Investigational Site
- Arkansas
  - Forrest City, Arkansas, Forente stater, 72335
    - Pfizer Investigational Site
- California
  - Berkeley, California, Forente stater, 94705
    - Pfizer Investigational Site
  - Concord, California, Forente stater, 94520
    - Pfizer Investigational Site
  - El Cajon, California, Forente stater, 92019
    - Pfizer Investigational Site
  - Encino, California, Forente stater, 91436
    - Pfizer Investigational Site
  - Fresno, California, Forente stater, 93720
    - Pfizer Investigational Site
  - Fullerton, California, Forente stater, 92835
    - Pfizer Investigational Site
  - Huntington Beach, California, Forente stater, 92648
    - Pfizer Investigational Site
  - Long Beach, California, Forente stater, 90806
    - Pfizer Investigational Site
  - Los Angeles, California, Forente stater, 90073
    - Pfizer Investigational Site
  - Rolling Hills Estates, California, Forente stater, 90274
    - Pfizer Investigational Site
  - San Diego, California, Forente stater, 92120
    - Pfizer Investigational Site
  - San Diego, California, Forente stater, 92128
    - Pfizer Investigational Site
  - San Jose, California, Forente stater, 95116
    - Pfizer Investigational Site
  - Santa Ana, California, Forente stater, 92704
    - Pfizer Investigational Site
  - Santa Barbara, California, Forente stater, 93105
    - Pfizer Investigational Site
  - Tustin, California, Forente stater, 92780
    - Pfizer Investigational Site
- Colorado
  - Denver, Colorado, Forente stater, 80220
    - Pfizer Investigational Site
  - Denver, Colorado, Forente stater, 80209
    - Pfizer Investigational Site
  - Denver, Colorado, Forente stater, 80206
    - Pfizer Investigational Site
  - Golden, Colorado, Forente stater, 80401
    - Pfizer Investigational Site
  - Longmont, Colorado, Forente stater, 80501
    - Pfizer Investigational Site
- Connecticut
  - Milford, Connecticut, Forente stater, 06460
    - Pfizer Investigational Site
- Delaware
  - Newark, Delaware, Forente stater, 19713
    - Pfizer Investigational Site
- District of Columbia
  - Washington, District of Columbia, Forente stater, 20010
    - Pfizer Investigational Site
  - Washington, District of Columbia, Forente stater, 20307
    - Pfizer Investigational Site
- Florida
  - Boca Raton, Florida, Forente stater, 33433
    - Pfizer Investigational Site
  - Chiefland, Florida, Forente stater, 32626
    - Pfizer Investigational Site
  - Green Cove Springs, Florida, Forente stater, 32043
    - Pfizer Investigational Site
  - Kissimmee, Florida, Forente stater, 34743
    - Pfizer Investigational Site
  - Lake City, Florida, Forente stater, 32025
    - Pfizer Investigational Site
  - Lake Mary, Florida, Forente stater, 32746
    - Pfizer Investigational Site
  - Miami, Florida, Forente stater, 33136
    - Pfizer Investigational Site
  - Opa Locka, Florida, Forente stater, 33054-3818
    - Pfizer Investigational Site
  - St. Cloud, Florida, Forente stater, 34769
    - Pfizer Investigational Site
  - Tampa, Florida, Forente stater, 33624
    - Pfizer Investigational Site
  - West Palm Beach, Florida, Forente stater, 33401
    - Pfizer Investigational Site
- Georgia
  - Atlanta, Georgia, Forente stater, 30342
    - Pfizer Investigational Site
  - Atlanta, Georgia, Forente stater, 30318-2513
    - Pfizer Investigational Site
  - Conyers, Georgia, Forente stater, 30013
    - Pfizer Investigational Site
  - Decatur, Georgia, Forente stater, 30035
    - Pfizer Investigational Site
- Hawaii
  - Honolulu, Hawaii, Forente stater, 96813
    - Pfizer Investigational Site
  - Honolulu, Hawaii, Forente stater, 96814
    - Pfizer Investigational Site
- Idaho
  - Hayden Lake, Idaho, Forente stater, 83835
    - Pfizer Investigational Site
- Illinois
  - Greenville, Illinois, Forente stater, 62246
    - Pfizer Investigational Site
  - Normal, Illinois, Forente stater, 61761
    - Pfizer Investigational Site
  - Olympia Fields, Illinois, Forente stater, 60461
    - Pfizer Investigational Site
  - Springfield, Illinois, Forente stater, 62704
    - Pfizer Investigational Site
- Indiana
  - Fishers, Indiana, Forente stater, 46038
    - Pfizer Investigational Site
  - Indianapolis, Indiana, Forente stater, 46229
    - Pfizer Investigational Site
  - Indianapolis, Indiana, Forente stater, 46254-5472
    - Pfizer Investigational Site
- Iowa
  - Des Moines, Iowa, Forente stater, 50314
    - Pfizer Investigational Site
  - Des Moines, Iowa, Forente stater, 50315
    - Pfizer Investigational Site
  - Dubuque, Iowa, Forente stater, 52002
    - Pfizer Investigational Site
- Kansas
  - Wichita, Kansas, Forente stater, 67203
    - Pfizer Investigational Site
- Kentucky
  - Louisville, Kentucky, Forente stater, 40213
    - Pfizer Investigational Site
  - Louisville, Kentucky, Forente stater, 40258
    - Pfizer Investigational Site
  - Mount Sterling, Kentucky, Forente stater, 40353
    - Pfizer Investigational Site
- Maryland
  - Baltimore, Maryland, Forente stater, 21204
    - Pfizer Investigational Site
  - Elkton, Maryland, Forente stater, 21921
    - Pfizer Investigational Site
  - Glen Burnie, Maryland, Forente stater, 21061
    - Pfizer Investigational Site
  - Wheaton, Maryland, Forente stater, 20902
    - Pfizer Investigational Site
- Massachusetts
  - Boston, Massachusetts, Forente stater, 02114
    - Pfizer Investigational Site
  - Springfield, Massachusetts, Forente stater, 01105
    - Pfizer Investigational Site
- Michigan
  - Ann Arbor, Michigan, Forente stater, 48104
    - Pfizer Investigational Site
  - Clinton, Michigan, Forente stater, 49236
    - Pfizer Investigational Site
  - Flint, Michigan, Forente stater, 48532
    - Pfizer Investigational Site
  - Muskegon, Michigan, Forente stater, 49444
    - Pfizer Investigational Site
- Minnesota
  - Saint Cloud, Minnesota, Forente stater, 56301
    - Pfizer Investigational Site
- Missouri
  - Kansas City, Missouri, Forente stater, 64116
    - Pfizer Investigational Site
  - Springfield, Missouri, Forente stater, 65807
    - Pfizer Investigational Site
- Nevada
  - Incline Village, Nevada, Forente stater, 89452
    - Pfizer Investigational Site
  - Las Vegas, Nevada, Forente stater, 89128
    - Pfizer Investigational Site
- New Jersey
  - Belvidere, New Jersey, Forente stater, 07823
    - Pfizer Investigational Site
  - New Brunswick, New Jersey, Forente stater, 08901
    - Pfizer Investigational Site
- New Mexico
  - Albuquerque, New Mexico, Forente stater, 87106
    - Pfizer Investigational Site
- New York
  - Albany, New York, Forente stater, 12208
    - Pfizer Investigational Site
  - Babylon, New York, Forente stater, 11702
    - Pfizer Investigational Site
  - Brooklyn, New York, Forente stater, 11224
    - Pfizer Investigational Site
  - Minneola, New York, Forente stater, 11501
    - Pfizer Investigational Site
  - New Hartford, New York, Forente stater, 13413
    - Pfizer Investigational Site
  - Syracuse, New York, Forente stater, 13210
    - Pfizer Investigational Site
  - Williamsville, New York, Forente stater, 14221
    - Pfizer Investigational Site
- North Carolina
  - Asheboro, North Carolina, Forente stater, 27203
    - Pfizer Investigational Site
  - Charlotte, North Carolina, Forente stater, 28227
    - Pfizer Investigational Site
  - Durham, North Carolina, Forente stater, 27713
    - Pfizer Investigational Site
  - Morehead City, North Carolina, Forente stater, 28557-3126
    - Pfizer Investigational Site
  - Raleigh, North Carolina, Forente stater, 27609
    - Pfizer Investigational Site
  - Tabor City, North Carolina, Forente stater, 28463
    - Pfizer Investigational Site
  - Winston-Salem, North Carolina, Forente stater, 27103
    - Pfizer Investigational Site
- Ohio
  - Columbus, Ohio, Forente stater, 43207
    - Pfizer Investigational Site
  - Dayton, Ohio, Forente stater, 45419
    - Pfizer Investigational Site
  - Kettering, Ohio, Forente stater, 45429
    - Pfizer Investigational Site
  - Marietta, Ohio, Forente stater, 45750
    - Pfizer Investigational Site
- Oregon
  - Portland, Oregon, Forente stater, 97210
    - Pfizer Investigational Site
  - Portland, Oregon, Forente stater, 97232
    - Pfizer Investigational Site
- Pennsylvania
  - Fogelsville, Pennsylvania, Forente stater, 18051
    - Pfizer Investigational Site
  - Hanover, Pennsylvania, Forente stater, 17331
    - Pfizer Investigational Site
  - Harrisburg, Pennsylvania, Forente stater, 17112
    - Pfizer Investigational Site
  - Jeannette, Pennsylvania, Forente stater, 15644
    - Pfizer Investigational Site
  - Jersey Shore, Pennsylvania, Forente stater, 17740
    - Pfizer Investigational Site
  - Lansdale, Pennsylvania, Forente stater, 19446
    - Pfizer Investigational Site
  - Melrose Park, Pennsylvania, Forente stater, 19027
    - Pfizer Investigational Site
  - Philadelphia, Pennsylvania, Forente stater, 19153-2326
    - Pfizer Investigational Site
- South Carolina
  - Charleston, South Carolina, Forente stater, 29412
    - Pfizer Investigational Site
  - North Myrtle Beach, South Carolina, Forente stater, 29582
    - Pfizer Investigational Site
- Texas
  - Beaumont, Texas, Forente stater, 77701
    - Pfizer Investigational Site
  - Dallas, Texas, Forente stater, 75246
    - Pfizer Investigational Site
  - Houston, Texas, Forente stater, 77008
    - Pfizer Investigational Site
  - Houston, Texas, Forente stater, 77079
    - Pfizer Investigational Site
  - Kaufman, Texas, Forente stater, 75142
    - Pfizer Investigational Site
  - San Antonio, Texas, Forente stater, 78229
    - Pfizer Investigational Site
  - San Marcos, Texas, Forente stater, 78666
    - Pfizer Investigational Site
  - Stephenville, Texas, Forente stater, 76401
    - Pfizer Investigational Site
  - Webster, Texas, Forente stater, 77598
    - Pfizer Investigational Site
- Vermont
  - South Burlington, Vermont, Forente stater, 05403
    - Pfizer Investigational Site
- Virginia
  - Richmond, Virginia, Forente stater, 23225-4017
    - Pfizer Investigational Site
  - Richmond, Virginia, Forente stater, 23294
    - Pfizer Investigational Site
- Washington
  - Federal Way, Washington, Forente stater, 98003
    - Pfizer Investigational Site
  - Spokane, Washington, Forente stater, 99204
    - Pfizer Investigational Site
  - Spokane, Washington, Forente stater, 99207
    - Pfizer Investigational Site
- West Virginia
  - Burnsville, West Virginia, Forente stater, 26335
    - Pfizer Investigational Site
Frankrike
- - Amiens cedex 1, Frankrike, 80094
    - Pfizer Investigational Site
  - Armentieres, Frankrike, 59427
    - Pfizer Investigational Site
  - Besancon, Frankrike, 25030
    - Pfizer Investigational Site
  - Bondy Cedex, Frankrike, 93143
    - Pfizer Investigational Site
  - Brest CEDEX, Frankrike, 29609
    - Pfizer Investigational Site
  - Chartres, Frankrike, 28000
    - Pfizer Investigational Site
  - Corbeil-Essonnes, Frankrike, 91100
    - Pfizer Investigational Site
  - Lorient Cedex, Frankrike, 56322
    - Pfizer Investigational Site
  - Paris Cedex 10, Frankrike, 75475
    - Pfizer Investigational Site
  - Paris Cedex 18, Frankrike, 75877
    - Pfizer Investigational Site
  - Rennes Cedex 2, Frankrike, 35203
    - Pfizer Investigational Site
Hellas
- - Athens, Hellas, 11527
    - Pfizer Investigational Site
  - Athens, Hellas, 15123
    - Pfizer Investigational Site
  - Thessaloniki, Hellas, 546 36
    - Pfizer Investigational Site
Italia
- - Catania, Italia, 95122
    - Pfizer Investigational Site
  - Genova, Italia, 16132
    - Pfizer Investigational Site
  - Milano, Italia, 20132
    - Pfizer Investigational Site
  - Napoli, Italia, 80131
    - Pfizer Investigational Site
  - Padova, Italia, 35128
    - Pfizer Investigational Site
  - Palermo, Italia, 90127
    - Pfizer Investigational Site
  - Roma, Italia, 00133
    - Pfizer Investigational Site
  - Udine, Italia, 33100
    - Pfizer Investigational Site
Kroatia
- - Zagreb, Kroatia, 10000
    - Pfizer Investigational Site
  - Zagreb, Kroatia, 10 000
    - Pfizer Investigational Site
Mexico
- Jalisco
  - Guadalajara, Jalisco, Mexico, 44340
    - Pfizer Investigational Site
- Nuevo Leon
  - Monterrey, Nuevo Leon, Mexico, 64460
    - Pfizer Investigational Site
Nederland
- - 's Hertogenbosch, Nederland, 5211 RW
    - Pfizer Investigational Site
  - Amsterdam, Nederland, 1105 AZ
    - Pfizer Investigational Site
  - Beek, Nederland, 6191 JW
    - Pfizer Investigational Site
  - Eindhoven, Nederland, 5631 BM
    - Pfizer Investigational Site
  - Venlo, Nederland, 5912 BL
    - Pfizer Investigational Site
Norge
- - Fornebu, Norge, 1364
    - Pfizer Investigational Site
  - Honefoss, Norge, 3515
    - Pfizer Investigational Site
  - Skedsmokorset, Norge, N-2020
    - Pfizer Investigational Site
  - Stavanger, Norge, 4068
    - Pfizer Investigational Site
Polen
- - Lask, Polen, 98-100
    - Pfizer Investigational Site
  - Lodz, Polen, 93-338
    - Pfizer Investigational Site
  - Lublin, Polen, 20-536
    - Pfizer Investigational Site
  - Warszawa, Polen, 02-097
    - Pfizer Investigational Site
Portugal
- - Aveiro, Portugal, 3814-096
    - Pfizer Investigational Site
  - Lisboa, Portugal, 1250-203
    - Pfizer Investigational Site
  - Lisboa, Portugal, 1349-019
    - Pfizer Investigational Site
  - Porto, Portugal, 4099-001
    - Pfizer Investigational Site
  - Torres Vedras, Portugal, 2560-324
    - Pfizer Investigational Site
Slovakia
- - Banska Bystrica, Slovakia, 975 17
    - Pfizer Investigational Site
  - Bratislava, Slovakia, 811 08
    - Pfizer Investigational Site
  - Martin, Slovakia, 036 01
    - Pfizer Investigational Site
Spania
- - Barcelona, Spania, 08036
    - Pfizer Investigational Site
  - Granada, Spania, 18012
    - Pfizer Investigational Site
  - Madrid, Spania, 28935
    - Pfizer Investigational Site
  - Malaga, Spania, 07300
    - Pfizer Investigational Site
  - Sevilla, Spania, 41014
    - Pfizer Investigational Site
  - Valencia, Spania, 46015
    - Pfizer Investigational Site
- A Coruña
  - Santiago de Compostela, A Coruña, Spania, 15706
    - Pfizer Investigational Site
- Barcelona
  - Badalona, Barcelona, Spania, 08916
    - Pfizer Investigational Site
- Las Palmas de Gran Canaria
  - Las Palmas, Las Palmas de Gran Canaria, Spania, 35016
    - Pfizer Investigational Site
- Santa Cruz de Tenerife
  - La Laguna, Santa Cruz de Tenerife, Spania, 38320
    - Pfizer Investigational Site
- Valencia
  - Alzira, Valencia, Spania, 46600
    - Pfizer Investigational Site
- Vizcaya
  - Bilbao, Vizcaya, Spania, 48013
    - Pfizer Investigational Site
Storbritannia
- - Bath, Storbritannia, BA2 3HT
    - Pfizer Investigational Site
  - Bath, Storbritannia, BA2 4BY
    - Pfizer Investigational Site
  - Birmingham, Storbritannia, B37 7TR
    - Pfizer Investigational Site
  - Birmingham, Storbritannia, B9 5SS
    - Pfizer Investigational Site
  - Bolton, Storbritannia, BL3 6TL
    - Pfizer Investigational Site
  - Canterbury, Storbritannia, CT1 3HX
    - Pfizer Investigational Site
  - Leicester, Storbritannia, LE1 5WW
    - Pfizer Investigational Site
  - Newcastle-upon-Tyne, Storbritannia, NE15 6TQ
    - Pfizer Investigational Site
  - Salford, Storbritannia, M6 8HD
    - Pfizer Investigational Site
  - Westbury, Storbritannia, BA13 3JD
    - Pfizer Investigational Site
- Cornwall
  - Penzance, Cornwall, Storbritannia, TR18 4JH
    - Pfizer Investigational Site
  - St. Austell, Cornwall, Storbritannia, PL26 7RL
    - Pfizer Investigational Site
- Devon
  - Plymouth, Devon, Storbritannia, PL6 8BX
    - Pfizer Investigational Site
- Hertfordshire
  - Letchworth, Hertfordshire, Storbritannia, SG6 4UB
    - Pfizer Investigational Site
- Middlesex
  - Ashford, Middlesex, Storbritannia, TW15 3EA
    - Pfizer Investigational Site
- Oxford
  - Headington, Oxford, Storbritannia, OX3 7LJ
    - Pfizer Investigational Site
- Surrey
  - Weybridge, Surrey, Storbritannia, KT15 2BH
    - Pfizer Investigational Site
  - Woking, Surrey, Storbritannia, GU22 7EY
    - Pfizer Investigational Site
- Warwickshire
  - Rugby, Warwickshire, Storbritannia, CV22 5PX
    - Pfizer Investigational Site
- Wiltshire
  - Warminster, Wiltshire, Storbritannia, BA12 9AA
    - Pfizer Investigational Site
- Yorkshire
  - Sheffield, Yorkshire, Storbritannia, S7 2DW
    - Pfizer Investigational Site
Sverige
- - Boras, Sverige, 503 30
    - Pfizer Investigational Site
  - Forshaga, Sverige, 667 32
    - Pfizer Investigational Site
  - Goteborg, Sverige, 412 55
    - Pfizer Investigational Site
  - Goteborg, Sverige, 41665
    - Pfizer Investigational Site
  - Göteborg, Sverige, 417 17
    - Pfizer Investigational Site
  - Harnosand, Sverige, 871 82
    - Pfizer Investigational Site
  - Helsingborg, Sverige, 251 87
    - Pfizer Investigational Site
  - Linkoping, Sverige, 581 85
    - Pfizer Investigational Site
  - Malmo, Sverige, 211 52
    - Pfizer Investigational Site
  - Stockholm, Sverige, 171 76
    - Pfizer Investigational Site
  - Vaxjo, Sverige, 351 85
    - Pfizer Investigational Site
Sør-Afrika
- Gauteng
  - Houghton, Gauteng, Sør-Afrika, 2198
    - Pfizer Investigational Site
- KwaZulu Natal
  - Umhlanga Rocks, KwaZulu Natal, Sør-Afrika, 4320
    - Pfizer Investigational Site
Tyskland
- - Altenburg, Tyskland, 04600
    - Pfizer Investigational Site
  - Aschaffenburg, Tyskland, 63739
    - Pfizer Investigational Site
  - Bad Doberan, Tyskland, 18209
    - Pfizer Investigational Site
  - Berlin, Tyskland, 10115
    - Pfizer Investigational Site
  - Berlin, Tyskland, 13355
    - Pfizer Investigational Site
  - Bonn, Tyskland, 53179
    - Pfizer Investigational Site
  - Chemnitz, Tyskland, 09130
    - Pfizer Investigational Site
  - Datteln, Tyskland, 45711
    - Pfizer Investigational Site
  - Dortmund, Tyskland, 44339
    - Pfizer Investigational Site
  - Eisenach, Tyskland, 99817
    - Pfizer Investigational Site
  - Emden, Tyskland, 26725
    - Pfizer Investigational Site
  - Essen, Tyskland, 45329
    - Pfizer Investigational Site
  - Falkensee, Tyskland, 14612
    - Pfizer Investigational Site
  - Friedberg, Tyskland, 86316
    - Pfizer Investigational Site
  - Fulda, Tyskland, 36037
    - Pfizer Investigational Site
  - Hamburg, Tyskland, 21073
    - Pfizer Investigational Site
  - Hohenmoelsen, Tyskland, 06679
    - Pfizer Investigational Site
  - Leipzig, Tyskland, 04103
    - Pfizer Investigational Site
  - Leverkusen, Tyskland, 51371
    - Pfizer Investigational Site
  - Marl, Tyskland, 45770
    - Pfizer Investigational Site
  - Meissen, Tyskland, 01662
    - Pfizer Investigational Site
  - Mittweida, Tyskland, 09648
    - Pfizer Investigational Site
  - Muenchen, Tyskland, D-80469
    - Pfizer Investigational Site
  - Muenster, Tyskland, 48145
    - Pfizer Investigational Site
  - Muenster, Tyskland, 48153
    - Pfizer Investigational Site
  - Neuss, Tyskland, 41460
    - Pfizer Investigational Site
  - Reinfeld, Tyskland, 23858
    - Pfizer Investigational Site
  - Riesa, Tyskland, 01587
    - Pfizer Investigational Site
  - Rossach, Tyskland, 96269
    - Pfizer Investigational Site
  - Schluechtern, Tyskland, 36381
    - Pfizer Investigational Site
  - Siegen, Tyskland, 57072
    - Pfizer Investigational Site
  - Suhl, Tyskland, 98529
    - Pfizer Investigational Site
  - Surwold, Tyskland, 26903
    - Pfizer Investigational Site
  - Villingen-Schwenningen, Tyskland, 78054
    - Pfizer Investigational Site
  - Wangen, Tyskland, 88239
    - Pfizer Investigational Site
  - Wangen / Allgaeu, Tyskland, 88239
    - Pfizer Investigational Site
  - Warburg, Tyskland, 34414
    - Pfizer Investigational Site
  - Wiesbaden, Tyskland, 65191
    - Pfizer Investigational Site
Østerrike
- - Vienna, Østerrike, A-1130
    - Pfizer Investigational Site
  - Wien, Østerrike, A-1030
    - Pfizer Investigational Site

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

All subjects who participated in a controlled trial of Exubera active within the last five years (17 protocols total)

Beskrivelse

Inclusion Criteria:

Previously participated in an eligible Exubera clinical trial
Willing to provide study doctor with at least one alternate contact person

Exclusion Criteria:

Participated in an investigational study of an unapproved drug since completing the Exubera trial
Ever used an other (non-Exubera) inhaled insulin

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Observasjonsmodeller: Kohort

Antall grupper / kohorter

Kohorter og intervensjoner

Gruppe / Kohort	Intervensjon / Behandling
Previously treated with Exubera	Legemiddel: Exubera Subjects who had been treated with Exubera in a prior Exubera controlled trial. Following initial use of randomized treatment, physicians and subjects were free to change regimens and dosing based on subject response to assigned treatment (as consistent with routine practice).
Previously treated with comparator Subjects who had been treated with a comparator (other diabetes treatment such as injected insulin) in a prior Exubera controlled trial.	Annen: Randomized diabetes therapy Subjects who had been treated with a comparator (other diabetes treatment including one or more of: subcutaneous insulin, sulfonylureas, biguanides, or thiazolinediones) in a prior Exubera controlled trial. Following initial use of randomized treatment, physicians and subjects were free to change regimens and dosing based on subject response to assigned treatment (as consistent with routine practice).

Gruppe / Kohort

Intervensjon / Behandling

Previously treated with Exubera

Legemiddel: Exubera

Subjects who had been treated with Exubera in a prior Exubera controlled trial. Following initial use of randomized treatment, physicians and subjects were free to change regimens and dosing based on subject response to assigned treatment (as consistent with routine practice).

Previously treated with comparator

Subjects who had been treated with a comparator (other diabetes treatment such as injected insulin) in a prior Exubera controlled trial.

Annen: Randomized diabetes therapy

Subjects who had been treated with a comparator (other diabetes treatment including one or more of: subcutaneous insulin, sulfonylureas, biguanides, or thiazolinediones) in a prior Exubera controlled trial.

Following initial use of randomized treatment, physicians and subjects were free to change regimens and dosing based on subject response to assigned treatment (as consistent with routine practice).

Hva måler studien?

Primære resultatmål

Resultatmål	Tiltaksbeskrivelse	Tidsramme
Rate of Primary Lung Cancer Mortality Tidsramme: Baseline from original trial up to Year 2 of this study	Reported deaths from primary lung cancer were adjudicated and classified into 4 categories: highly likely (clinical, radiographic, and/or histological data consistent with primary lung cancer); likely (some information may have been missing for definite diagnosis); unlikely; insufficient information. Highly likely and likely cases used to report rate and rate ratio of primary lung cancer mortality. Includes events from the start of the original trial to the end of FUSE.	Baseline from original trial up to Year 2 of this study

Sekundære resultatmål

Resultatmål	Tiltaksbeskrivelse	Tidsramme
Rate of Primary Lung Cancer Mortality Among Former Smokers Tidsramme: Baseline from original trial up to Year 2 of this study	Reported deaths from primary lung cancer were adjudicated and classified into 4 categories: highly likely (clinical, radiographic, and/or histological data consistent with primary lung cancer); likely (some information may have been missing for definite diagnosis); unlikely; insufficient information. Highly likely and likely cases used to report rate and rate ratio of primary lung cancer mortality. Includes events from the start of the original trial to the end of FUSE.	Baseline from original trial up to Year 2 of this study
Rate of All-cause Mortality Tidsramme: Baseline from original trial up to Year 2 of this study	The rate and rate ratio of all-cause mortality that occurred anytime from the start of the original trial to the end of FUSE.	Baseline from original trial up to Year 2 of this study
Rate of Primary Lung Cancer Diagnosis Tidsramme: Baseline from original trial up to Year 2 of this study	The rate and rate ratio of lung cancer adjudicated as highly likely (clinical, radiographic, and/or histological data consistent with primary lung cancer) or likely (some information may have been missing for definite diagnosis) to be newly diagnosed primary lung cancer that occurred anytime from the start of the original trial to the end of FUSE.	Baseline from original trial up to Year 2 of this study

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Pfizer

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Gatto NM, Koralek DO, Bracken MB, Duggan WT, Lem J, Klioze S, Koch GG, Wise RA, Cohen RB, Jackson NC. Lung Cancer-Related Mortality With Inhaled Insulin or a Comparator: Follow-Up Study of patients previously enrolled in Exubera Controlled Clinical Trials (FUSE) Final Results. Diabetes Care. 2019 Sep;42(9):1708-1715. doi: 10.2337/dc18-2529. Epub 2019 Jul 22.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. august 2008

Primær fullføring (Faktiske)

1. januar 2012

Studiet fullført (Faktiske)

1. januar 2012

Datoer for studieregistrering

Først innsendt

12. august 2008

Først innsendt som oppfylte QC-kriteriene

12. august 2008

Først lagt ut (Anslag)

14. august 2008

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

23. oktober 2012

Siste oppdatering sendt inn som oppfylte QC-kriteriene

24. september 2012

Sist bekreftet

1. september 2012

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Observational Study Exubera

Andre studie-ID-numre

A2171121

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Sukkersyke

State University of New York at Buffalo
Medical University of South Carolina

Fullført

Økonomiske insentiver Telefonutdanning og ferdighetsprøve i afroamerikanere med diabetes (FITEST) (FITEST)

Sukkersyke | Type 2 diabetes mellitus | Voksendiabetes mellitus | Ikke-insulinavhengig diabetes mellitus | Ikke-insulinavhengig diabetes mellitus, type II

Forente stater
University of Colorado, Denver
Massachusetts General Hospital; Beta Bionics, Inc.

Fullført

Gjennomførbarhet av lukket sløyfe automatisert insulinleveringssystem av primærhelse og endokrinologi, personlig og via telehelse

Diabetes mellitus, type 1 | Type 1 diabetes | Diabetes type 1 | Type 1 diabetes mellitus | Autoimmun diabetes | Diabetes mellitus, insulinavhengig | Juvenil-Debut Diabetes | Diabetes, autoimmun | Insulinavhengig diabetes mellitus 1 | Diabetes mellitus, insulinavhengig, 1 | Diabetes mellitus, sprø | Diabetes mellitus... og andre forhold

Forente stater
Superior University

Aktiv, ikke rekrutterende

AI-drevet MRF Type 2 Diabetes som integrerer DHT IF og Motstandstrening til OM og Funksjonelle Utfall

Type 2 diabetes mellitus 1

Pakistan
Sanofi

Fullført

Sammenligning av SAR341402 med NovoLog/NovoRapid hos voksne pasienter med diabetes mellitus som også bruker Insulin Glargine (GEMELLI1)

Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus

Ungarn, Den russiske føderasjonen, Tyskland, Polen, Japan, Forente stater, Finland
Guang Ning

Rekruttering

Kina Diabetes Registry av Metabolic Management Center (CDR-MMC)

Type 2 diabetes mellitus | Type 1 diabetes mellitus | Monogenetisk diabetes | Pankreatogen diabetes | Legemiddelindusert diabetes mellitus | Andre former for diabetes mellitus

Kina
Meir Medical Center

Fullført

Effekten av DBcare, et kosttilskudd på diabeteskontroll

Diabetes mellitus type 2 | Diabetes mellitus, ikke-insulinavhengig | Diabetes mellitus, om oral hypoglykemisk behandling | Voksen type diabetes mellitus

Israel
Hoffmann-La Roche
Roche Diagnostics

Fullført

A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.

Diabetes mellitus type 2, diabetes mellitus type 1

Tyskland
Vanderbilt University Medical Center

Rekruttering

Kontinuerlig glukoseovervåking for poliklinisk diabetesbehandling etter utskrivning av sykehus

Hyperglykemi | Type 2 diabetes mellitus (T2DM) | Type 1 diabetes mellitus (T1DM)

Forente stater
Peking Union Medical College Hospital

Ukjent

Foreløpig undersøkelse av driftsstandardene for insulinpumpeinstallasjon i diabetesklinikken i Kina

Type 2 diabetes mellitus | Type 1 diabetes mellitus | Svangerskapsdiabetes mellitus | Pankreatogen diabetes mellitus | Pregestasjonell diabetes mellitus | Diabetespasienter i perioperativ periode

Kina
University of California, San Francisco
Juvenile Diabetes Research Foundation

Fullført

Imatinib-behandling ved nylig oppstått type 1-diabetes mellitus

Type 1 diabetes mellitus | Diabetes mellitus, type I | Insulinavhengig diabetes mellitus 1 | Diabetes mellitus, insulinavhengig, 1 | IDDM

Forente stater, Australia

Follow-Up Study for Exubera (FUSE)

An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials

Studieoversikt

Status

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

Studietype

Registrering (Faktiske)

Kontakter og plasseringer

Studiesteder

Deltakelseskriterier

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

Tar imot friske frivillige

Kjønn som er kvalifisert for studier

Prøvetakingsmetode

Studiepopulasjon

Beskrivelse

Studieplan

Hvordan er studiet utformet?

Designdetaljer

Antall grupper / kohorter

Kohorter og intervensjoner

Gruppe / Kohort

Intervensjon / Behandling

Hva måler studien?

Primære resultatmål

Resultatmål

Tiltaksbeskrivelse

Tidsramme

Sekundære resultatmål

Resultatmål

Tiltaksbeskrivelse

Tidsramme

Samarbeidspartnere og etterforskere

Sponsor

Publikasjoner og nyttige lenker

Generelle publikasjoner

Studierekorddatoer

Studer hoveddatoer

Studiestart

Primær fullføring (Faktiske)

Studiet fullført (Faktiske)

Datoer for studieregistrering

Først innsendt

Først innsendt som oppfylte QC-kriteriene

Først lagt ut (Anslag)

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

Siste oppdatering sendt inn som oppfylte QC-kriteriene

Sist bekreftet

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Andre studie-ID-numre

Kliniske studier på Sukkersyke

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Jamaica

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder